In recent years, the field of adult vaccination has undergone significant advances, introducing novel vaccines and updating guidelines for existing ones. As healthcare professionals, staying abreast of these developments is crucial for patient care.
There has been noteworthy progress in the development of new vaccines. One example is the Herpes Zoster Subunit (HZ/su) vaccine, approved by the FDA in 2017 for adults aged 50 and above. It offers over 90% efficacy against shingles and postherpetic neuralgia, surpassing the previously used Zostavax vaccine.
Guidelines for existing vaccines have also been revised. The Advisory Committee on Immunization Practices (ACIP) now recommends a single dose of Tdap vaccine for all adults who have not previously received it, followed by a Td booster every 10 years. Moreover, the pneumococcal vaccine sequence has been updated with the PCV13 vaccine no longer routinely recommended for all adults aged 65 and older.
Updated vaccine schedules have been released to accommodate these changes. For instance, the HZ/su vaccine requires two doses, administered 2-6 months apart. Furthermore, the HPV vaccine series can now be started in adults up to age 45, an increase from the previous age limit of 26.
With new vaccines and guidelines, safety and efficacy continue to be paramount. All vaccines undergo rigorous testing before approval, and post-marketing surveillance ensures ongoing safety. The high efficacy of new vaccines like HZ/su demonstrates the success of these processes.
Keeping up-to-date with advances in adult vaccination is essential for healthcare professionals. The introduction of novel vaccines and updates to existing guidelines and schedules ensures improved patient outcomes. Continued vigilance in monitoring vaccine safety and efficacy remains a critical aspect of this evolving field.
1.
A Lot Can Be Said About You by Including Yourself in Photos.
2.
A new blood test greatly increases the ability to detect cancer.
3.
Novel biomarker has potential for predicting and treating skin cancer metastasis
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
1.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
2.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
3.
Contemporary Frameworks in Oncology Across Clinical Settings
4.
What is Mullerian and How Does it Affect Your Health
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Common Causes of Abnormal Blood Counts
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Understanding Cancer: Early Detection and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation